Publicaciones en las que colabora con Juan Manuel Alcalde Navarrete (15)

2021

  1. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group

    Radiotherapy and Oncology, Vol. 154, pp. 128-134

2017

  1. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study

    Radiotherapy and Oncology, Vol. 122, Núm. 2, pp. 255-259

2015

  1. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome

    Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322

  2. Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited

    Brachytherapy, Vol. 14, Núm. 4, pp. 565-570

2014

  1. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model

    Brachytherapy, Vol. 13, Núm. 4, pp. 400-404

  2. Volume of high-dose regions and likelihood of locoregional control after perioperative high-dose-rate brachytherapy: Do hotter implants work better?

    Brachytherapy, Vol. 13, Núm. 6, pp. 591-596

2012

  1. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

2011

  1. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  2. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

2010

  1. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, Núm. 2, pp. 137-143

2009

  1. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer

    Brachytherapy, Vol. 8, Núm. 1, pp. 26-33

2006

  1. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study

    Brachytherapy, Vol. 5, Núm. 1, pp. 32-40

2005

  1. Initial results of a prospective clinical study of cisplatin/paclitaxelbased hyperfiractionated chemoradiation (3DCRTHF) in squamous cell head and neck cancer (HNC) stages III-IV

    EJC SUPPLEMENTS

2004

  1. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas

    Brachytherapy, Vol. 3, Núm. 4, pp. 196-200

1997

  1. IORT in the management of locally advanced or recurrent head and neck cancer

    Frontiers of Radiation Therapy and Oncology, Vol. 31, pp. 122-125